Stock Report

Download full stock data and analysis for free Last Updated: 04-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Dr. Reddy's Laboratories - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$12.03

up-down-arrow $-0.14 (-1.15%)

As on 03-Sep-2026 16:10EDT

Market cap

info icon

$10,088 Mln

Revenue (TTM)

info icon

$332,834 Mln

P/E Ratio

info icon

28.8

P/B Ratio

info icon

2.5

Div. Yield

info icon

0.7 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 6.36 -4.99 -0.43 34.55 27.24
EBIT -- -- -53.96 -0.35 16.98
Net Profit 103.85 -68.10 -40.27 7.85 40.83
EPS 100.10 -68.52 -41.56 -24.40 37.02
Book Value -- -- 10.79 16.86 174.37
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 22.7521.7811.0817.4324.46
Net Margin info ----9.96----
Return on equity info 17.6719.778.8812.8318.42
Return on Capital info 15.9917.59--10.9216.61
Return on Assets info 12.3513.524.768.5012.84
Debt to Equity (x) info ----0.000.210.14

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
10.92
16.61
20.43
19.23
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

8.88

Lower than Peers by 10.09

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
8.88
12.83
18.42
21.77
21.38
Peer Median
18.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

4.76

Higher than Peers by 1.90

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
4.76
8.50
12.84
15.70
14.66
Peer Median
2.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

11.08

Lower than Peers by 4.75

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
11.08
17.43
24.46
26.36
25.13
Peer Median
15.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

9.96

Higher than Peers by 1.73

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
9.96
12.76
17.37
19.95
18.33
Peer Median
8.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-0.43

Lower than Peers by 8.48

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
-0.43
0.09
0.17
0.14
0.15
Peer Median
8.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-53.96

Lower than Peers by 62.23

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
-53.96
-22.61
8.20
19.07
85.82
Peer Median
8.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-40.27

Lower than Peers by 48.01

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
-40.27
-20.26
1.54
23.56
91.22
Peer Median
7.73
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-41.56

Lower than Peers by 51.95

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
-41.56
-0.20
0.02
0.23
0.91
Peer Median
10.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

9.58

Higher than Peers by 4.70

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
9.58
--
--
--
--
Peer Median
4.87
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
0.21
0.14
0.07
0.06
Peer Median
0.59
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.16

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
0.16
0.17
0.12
0.05
0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.90

Higher than Peers by 0.25

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
1.90
1.80
1.92
2.58
2.38
Peer Median
1.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.39

Higher than Peers by 0.19

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
1.39
1.35
1.37
1.92
1.81
Peer Median
1.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

10.86

Higher than Peers by 6.09

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
10.86
15.66
28.14
43.00
43.27
Peer Median
4.77
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

37.38

Higher than Peers by 16.11

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
37.38
28.07
33.73
34.15
33.84
Peer Median
21.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.48

Higher than Peers by 0.08

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
0.48
0.67
0.74
0.79
0.80
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
107.99
115.08
116.80
121.42
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
159.82
181.99
177.35
170.66
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
57.76
56.23
62.27
57.99
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Reddy's Laboratories - ADR
--
210.04
240.84
231.88
234.09
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...